Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents

MLA

Igal Moarof, et al. Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents. Jan. 2019. EBSCOhost, https://doi.org/10.7892/boris.134889.

APA

Igal Moarof, Florim Cuculi, Daniel Weilenmann, David Tüller, Fabio Rigamonti, Christoph Kaiser, Thomas Pilgrim, Marco Valgimigli, Marco Roffi, Olivier Muller, Stephan Windecker, Jonas Lanz, Peter Jüni, Dik Heg, Stéphane Cook, & Juan F. Iglesias. (2019). Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents. https://doi.org/10.7892/boris.134889

Chicago

Igal Moarof, Florim Cuculi, Daniel Weilenmann, David Tüller, Fabio Rigamonti, Christoph Kaiser, Thomas Pilgrim, et al. 2019. “Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents,” January. doi:10.7892/boris.134889.